JP2023525137A5 - - Google Patents

Info

Publication number
JP2023525137A5
JP2023525137A5 JP2022568879A JP2022568879A JP2023525137A5 JP 2023525137 A5 JP2023525137 A5 JP 2023525137A5 JP 2022568879 A JP2022568879 A JP 2022568879A JP 2022568879 A JP2022568879 A JP 2022568879A JP 2023525137 A5 JP2023525137 A5 JP 2023525137A5
Authority
JP
Japan
Prior art keywords
compound
methylsulfonyl
methyl
alkyl
pyran
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Granted
Application number
JP2022568879A
Other languages
English (en)
Japanese (ja)
Other versions
JP2023525137A (ja
JP7789697B2 (ja
Filing date
Publication date
Application filed filed Critical
Priority claimed from PCT/FI2021/050353 external-priority patent/WO2021229152A1/en
Publication of JP2023525137A publication Critical patent/JP2023525137A/ja
Publication of JP2023525137A5 publication Critical patent/JP2023525137A5/ja
Priority to JP2025244683A priority Critical patent/JP2026048803A/ja
Application granted granted Critical
Publication of JP7789697B2 publication Critical patent/JP7789697B2/ja
Active legal-status Critical Current
Anticipated expiration legal-status Critical

Links

JP2022568879A 2020-05-14 2021-05-12 Cyp11a1阻害剤 Active JP7789697B2 (ja)

Priority Applications (1)

Application Number Priority Date Filing Date Title
JP2025244683A JP2026048803A (ja) 2020-05-14 2025-12-10 Cyp11a1阻害剤

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
FI20205486 2020-05-14
FI20205486 2020-05-14
PCT/FI2021/050353 WO2021229152A1 (en) 2020-05-14 2021-05-12 Cyp11a1 inhibitors

Related Child Applications (1)

Application Number Title Priority Date Filing Date
JP2025244683A Division JP2026048803A (ja) 2020-05-14 2025-12-10 Cyp11a1阻害剤

Publications (3)

Publication Number Publication Date
JP2023525137A JP2023525137A (ja) 2023-06-14
JP2023525137A5 true JP2023525137A5 (https=) 2024-05-22
JP7789697B2 JP7789697B2 (ja) 2025-12-22

Family

ID=76325569

Family Applications (2)

Application Number Title Priority Date Filing Date
JP2022568879A Active JP7789697B2 (ja) 2020-05-14 2021-05-12 Cyp11a1阻害剤
JP2025244683A Pending JP2026048803A (ja) 2020-05-14 2025-12-10 Cyp11a1阻害剤

Family Applications After (1)

Application Number Title Priority Date Filing Date
JP2025244683A Pending JP2026048803A (ja) 2020-05-14 2025-12-10 Cyp11a1阻害剤

Country Status (8)

Country Link
US (1) US20230192677A1 (https=)
EP (1) EP4149924A1 (https=)
JP (2) JP7789697B2 (https=)
KR (1) KR20230010723A (https=)
CN (1) CN115551831A (https=)
AU (1) AU2021269872A1 (https=)
CA (1) CA3178067A1 (https=)
WO (1) WO2021229152A1 (https=)

Families Citing this family (16)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP4313946A4 (en) * 2021-03-26 2025-03-12 Jacobio Pharmaceuticals Co., Ltd. NEW COMPOUNDS AS STING AGONISTS AND THEIR USES
US20250367184A1 (en) * 2021-09-28 2025-12-04 Orion Corporation Cyp11a1 inhibitor for use in the treatment of prostate cancer
WO2023084158A1 (en) * 2021-11-10 2023-05-19 Orion Corporation Cyp11a1 inhibitors
CN115304591B (zh) * 2022-07-08 2024-10-01 广州中医药大学(广州中医药研究院) 一种桥环甾体合成酶抑制剂及其制备方法和应用
CN118307519A (zh) * 2023-01-06 2024-07-09 上海闻耐医药科技有限公司 一类cyp11a1抑制剂化合物及其制备方法和用途
CN121002012A (zh) * 2023-03-29 2025-11-21 西藏海思科制药有限公司 Cyp11a1抑制剂及其用途
WO2024199421A1 (zh) * 2023-03-30 2024-10-03 山东轩竹医药科技有限公司 Cyp11a1抑制剂
CN121039123A (zh) * 2023-04-21 2025-11-28 西藏海思科制药有限公司 Cyp11a1抑制剂及其用途
KR20260040160A (ko) * 2023-05-11 2026-03-24 셴젠 이오노바 라이프 사이언스 시오., 엘티디. Cyp11a1 억제제로서의 신규 화합물 및 그 용도
WO2025021182A1 (en) * 2023-07-27 2025-01-30 Acerand Therapeutics (Hong Kong) Limited Cyp11a1 inhibitors
WO2025051216A1 (zh) * 2023-09-08 2025-03-13 深圳众格生物科技有限公司 一种cyp11a1抑制剂、其制备方法及其应用
WO2025168117A1 (zh) * 2024-02-08 2025-08-14 盛睿泽华医药科技(苏州)有限公司 一种多环化合物及其制备方法和应用
WO2025237211A1 (zh) * 2024-05-11 2025-11-20 辽宁海思科制药有限公司 一种cyp11a1抑制剂的晶型物及其制备方法和应用
WO2025247149A1 (zh) * 2024-05-27 2025-12-04 辽宁海思科制药有限公司 一种cyp11a1抑制剂的盐及其晶型、其制备方法和应用
WO2026002207A1 (en) * 2024-06-28 2026-01-02 Acerand Therapeutics (Hong Kong) Limited Heterocyclic compounds as cyp11a1 inhibitors
WO2026040949A1 (zh) * 2024-08-19 2026-02-26 辽宁海思科制药有限公司 一种cyp11a1抑制剂的药物组合物及其制备方法和用途

Family Cites Families (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP1471063A1 (en) 2003-02-28 2004-10-27 Exonhit Therapeutics S.A. Compounds and methods of treating cell proliferative diseases, retinopathies and arthritis
WO2013056015A1 (en) 2011-10-14 2013-04-18 Incyte Corporation Isoindolinone and pyrrolopyridinone derivatives as akt inhibitors
JPWO2017014170A1 (ja) 2015-07-17 2018-04-26 武田薬品工業株式会社 複素環化合物
AR110412A1 (es) * 2016-12-22 2019-03-27 Orion Corp Inhibidores de la cyp11a1

Similar Documents

Publication Publication Date Title
JP2023525137A5 (https=)
AU2014291711B2 (en) Autotaxin inhibitors comprising a heteroaromatic ring-benzyl-amide-cycle core
ES2536191T3 (es) Derivados de sulfonamida
RU2453544C2 (ru) Фунгицидные азоциклические амиды
RU2317291C2 (ru) Производные пиримидина в качестве модуляторов рецептора инсулинподобного фактора роста 1 (igf-1), фармацевтическая композиция, способы получения (варианты) и применение
JP2024532374A (ja) Tead阻害剤を含む医薬品組み合わせ物及び癌の治療のためのその使用
JP2020516671A5 (https=)
IL263511A (en) 1h-pyrazolo[4,3-b]pyridines as pde1 inhibitors
JP2011500826A5 (https=)
RU2013157374A (ru) Производное индазола и пирролопиридина и его фармацевтическое применение
RU2006127572A (ru) Полигетероциклические соединения и их применение в качестве антагонистов метаботропного рецептора глутамата
JP2006502134A5 (https=)
RU2019132212A (ru) Селективные ингибиторы hdac6
IL295076A (en) Piperidinone derivatives as mdm2 inhibitors for cancer therapy
JP2009541311A5 (https=)
JPWO2012102254A1 (ja) インドール誘導体、またはその薬理学的に許容される塩
JP2013527847A5 (https=)
JP2017519836A5 (https=)
JP2009515814A5 (https=)
JP7073533B2 (ja) スピロピペリジン系ニコチン性アセチルコリン受容体アロステリック調節剤
JP2013531070A5 (https=)
AU2009315930A1 (en) Heteroaromatic compounds for use as HIF inhibitors
HRP20240297T1 (hr) Derivati alfa-d-galaktopiranozida
JP2012087129A5 (https=)
JP2018515489A5 (https=)